Mimopath®-based Vaccines
In addition to the intranasal Mimopath®-based influenza vaccine, our scientists and collaborators have demonstrated in animal models that Mimopath-based vaccines also protect against live parasites (malaria) and bacteria (Streptococcus pneumonia, Yersinia pestis). Moreover, Mimopath®-based vaccines were shown to be effective both as an injectable and an intranasal vaccine. This forms the basis for a broad application of this new and innovative vaccine technology